LITTEE SAM: Open Payments
NPI 1316444508 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 14 payments from 9 companies in 2025. Trend: 2023 $536 · 2024 $178 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 1 | $114 |
| Merck Sharp & Dohme LLC | 4 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| CARDIVA MEDICAL, INC. | 1 | $25 |
| Boston Scientific Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Kestra Medical Technology Services, Inc. | 1 | $14 |
Products named: VERQUVO, JARDIANCE, CAPVAXIVE, LEQVIO, CARDIVA VASCADE 6/7F VCS, ELIQUIS, WATCHMAN FLX, SHINGRIX.
Industry payments across TX — which companies pay providers there.
